Perioperative management of anticoagulation

The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.

Editor, – The article 'The perioperative management of anticoagulation'(Aust Prescr 2000;23:13-6) discusses surgical procedures in patients who for one reason or another are on long-term warfarin. Whilst there may be some indications for warfarin that can be stopped for a few days without risk, there are others in which the warfarin must be ceased and heparin begun so the operation can take place. The patient then requires to be put back on warfarin at a suitable time, a process which is not easy and takes several days, often as an inpatient.

When Professor Hughes from Wales was in Australia many years ago he mentioned to me that he had performed certain operations without stopping the warfarin. Since then I have done a number of perianal procedures, hernias and even a laparotomy without stopping the warfarin and in only one hernia was there a significant haematoma. It is important of course to check that the INR is in therapeutic range before operating on patients on warfarin, and haemostasis must be meticulous, while careful observation of the patient postoperatively is also essential.

There would appear to be considerable merit in certain cases, in experienced hands, for keeping the patient on oral anticoagulant for selected surgical procedures.

Kevin Orr
Kogarah, NSW

Dr Andrew Grigg, one of the authors of the article, comments:
Unfortunately there are few prospective studies which address the issue of what constitutes a 'safe' INR for various surgical procedures. A study performed almost 40 years ago1 randomised 60 patients undergoing cholecystectomy or gastric resection to either no anticoagulation or anticoagulation to achieve a thrombo test concentration of 15-20% of normal, equating to an INR of 1.6-2.1. There was no overall significant difference in operative, 24 hour or 72 hour blood loss between the two groups; four of 30 patients in the treated group had blood loss exceeding 1500 mL in the first 24 hours compared with one of 30 in the control group.

I put this issue to Professor Jack Hirsh, co-author of a review article on management of anticoagulation before and after elective surgery.2 His reply was, 'If a surgeon chooses to do so, it would be reasonable to continue warfarin at an INR of about 1.5 during surgery. However, I know of no hard data supporting the safety of this approach.'

The paucity of data gives the opportunity for surgeons and haematologists to collaborate in a prospective study so that anecdotal experience could be replaced by evidence-based medicine.


  1. Rustad H, Myhre E. Surgery during anticoagulant treatment. The risk of increased bleeding in patients on oral anticoagulant treatment. Acta Med Scand 1963;173:115-9.
  2. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-11.